Hallucinogens: all 554 studies that test it
Page 6 of 6. Open to participants first (189), then studies with results posted, then the rest; newest registration first within each.
- Influence of Bupropion on the Effects of MDMACompletedNCT01771874Phase 1
- Safety and Tolerability of Namisol in the ElderlyCompletedNCT01740960Phase 1
- U of A/ U of M Beans and Peas Health Claim ProjectCompletedNCT01661543Not applicable
- Effects of MDMA and Methylphenidate on Social CognitionCompletedNCT01616407Early Phase 1
- Delta-THC in DementiaCompletedNCT01608217Phase 2
- Cannabinoid Modulation of PainCompletedNCT01595620Early Phase 1
- The Effects of ∆-9-THC and Naloxone in HumansCompletedNCT01591629Early Phase 1
- The Analgesic Efficacy of Δ9-THC (Namisol®) in Patients With Persistent Postsurgical Abdominal PainCompletedNCT01562483Phase 2
- Δ9-THC (Namisol®) in Chronic Pancreatitis Patients Suffering From Persistent Abdominal PainCompletedNCT01551511Phase 2
- Neuroprotection by Cannabinoids in Huntington's DiseaseCompletedNCT01502046Phase 2
- Emotional Effects of Methylphenidate and MDMA in Healthy SubjectsCompletedNCT01465685Phase 1
- Comparative Bioavailability of Dronabinol Oral Solution Versus Branded Capsule 5 mg Under Fasting ConditionsCompletedNCT01448772Phase 1
- -Methylenedioxymethamphetamine (MDMA, Ecstasy) Induced Changes in Drug Metabolism: Gender and Genetic PolymorphismsCompletedNCT01447472Phase 1
- Psychological Effects of Methylenedioxymethamphetamine (MDMA) When Administered to Healthy VolunteersCompletedNCT01404754Phase 1
- Pharmacological Interaction Between Doxazosin and Methylenedioxymethamphetamine (MDMA)CompletedNCT01386177Phase 1
- Bioavailability Study of Dronabinol Capsules 10 mg Under Fasting ConditionsCompletedNCT01380457Phase 1
- Efficacy Study of Δ9-THC to Treat Chronic Abdominal PainCompletedNCT01318369Phase 2
- Delta-THC in Behavioral Disturbances in DementiaCompletedNCT01302340Phase 2
- Pharmacological Interaction Between Carvedilol and Methylenedioxymethamphetamine (MDMA)CompletedNCT01270672Not applicable
- The Effects of Cannabidiol and ∆-9-THC in HumansCompletedNCT01180374Early Phase 1
- Placebo Controlled Study of Sublingual Salvinorin ACompletedNCT01149824Not applicable
- Efficacy Trial of Oral Tetrahydrocannabinol in Patients With FibromyalgiaStatus unknownNCT01149018Not applicable
- Neurobiology and Pharmacokinets of Acute MDMA AdministrationCompletedNCT01148342Phase 1
- Pharmacological Interaction Between Clonidine and Methylenedioxymethamphetamine (MDMA)CompletedNCT01136278Phase 1
- Effects of Sativex(Registered Trademark) and Oral THC on Attention, Affect, Working Memory, Reversal Learning, Physiology and Brain ActivationCompletedNCT01037608Phase 1
- Human Psychopharmacology of Salvinorin ACompletedNCT00996411Phase 1
- Interaction Between Duloxetine and 3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy)CompletedNCT00990067Phase 1
- Effects of Delta-9-THC and Iomazenil in Healthy HumansCompletedNCT00982982Early Phase 1
- Psilocybin-Assisted Psychotherapy for Anxiety in People With Stage IV MelanomaWithdrawnNCT00979693Phase 2
- Add on Study on Δ9-THC Treatment for Posttraumatic Stress Disorders (PTSD)Status unknownNCT00965809Phase 4
- Efficacy and Safety of the Pain Relieving Effect of Dronabinol in Central Neuropathic Pain Related to Multiple SclerosisCompletedNCT00959218Phase 3
- Pharmacological Interaction Between Pindolol and MDMA (3,4-Methylenedioxymethamphetamine)CompletedNCT00895804Phase 1
- Interaction Between Reboxetine and 3,4-Methylenedioxymethamphetamine: Pharmacodynamics (PD) and Pharmacokinetics (PK)CompletedNCT00886886Phase 1
- Role of Serotonin in Acute and Subacute MDMA EffectsCompletedNCT00838305Not applicable
- Clinical Pharmacology of MDA [3,4-methylenedioxyamphetamine]CompletedNCT00823407Not applicable
- Randomized Placebo-Controlled Crossover Trial With THC (Delta 9-Tetrahydrocannabinol) for the Treatment of Cramps in Amyotrophic Lateral Sclerosis (ALS)CompletedNCT00812851Not applicable
- Psilocybin and Spiritual PracticeCompletedNCT00802282Phase 1
- Cannabinoid Receptor (CB1) Agonist Treatment in Severe Chronic Anorexia NervosaCompletedNCT00760695Phase 3
- Cannabinoids, Neural Synchrony, and Information ProcessingCompletedNCT00708994Early Phase 1
- Effects of Salvinorin A in Healthy ControlsCompletedNCT00700596Early Phase 1
- Pharmacogenetics of Cannabinoid ResponseCompletedNCT00678730Early Phase 1
- Dronabinol Versus Standard Ondansetron Antiemetic Therapy in Preventing Delayed-Onset Chemotherapy-Induced Nausea and VomitingCompletedNCT00642512Phase 3
- Dronabinol Versus Placebo in Treatment and Prevention of Highly Active Anti-Retroviral Therapy (HAART)-Related Nausea and VomitingCompletedNCT00642499Phase 2
- Investigating the Acute Effects of THC on Functional Brain SystemsCompletedNCT00628706Phase 1
- Cannabinoid Receptor Function & AlcoholismCompletedNCT00624715Phase 1
- Ph1 Marinol Interaction Study - Part 1 - 1TerminatedNCT00438139Phase 1
- Efficacy of Dronabinol for the Treatment of Cervical DystoniaStatus unknownNCT00418925Phase 2
- Effect of Delta-9-Tetrahydrocannabinol on the Prevention of Chronic Pain in Patients With Acute CRPS (ETIC-Study)Status unknownNCT00377468Phase 2
- Effect of Lofexidine and Oral THC on Marijuana Withdrawal and RelapseCompletedNCT00373503Phase 2
- Orexigenic Therapy With Delta-9-tetrahydrocannabinol in Advanced Cancer Patients With Chemosensory Abnormalities - a Pilot StudyCompletedNCT00316563Phase 2
- Effects of Psilocybin in Advanced-Stage Cancer Patients With AnxietyCompletedNCT00302744Phase 1/2
- Study to Evaluate the Efficacy of Dronabinol (Marinol) as Add-On Therapy for Patients on Opioids for Chronic PainCompletedNCT00153192Phase 2/3
- Comparing the Effects of Smoked and Oral Marijuana in Individuals With HIV/AIDSCompletedNCT00079560Phase 1/2
- A Phase I/II Study to Evaluate Single Agent and Combination Therapy With Megestrol Acetate and Dronabinol for the Treatment of HIV-Wasting SyndromeCompletedNCT00000737Phase 1